X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with AJANTA PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs AJANTA PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB AJANTA PHARMA UNICHEM LAB/
AJANTA PHARMA
 
P/E (TTM) x 32.6 27.8 117.0% View Chart
P/BV x 3.4 11.5 29.9% View Chart
Dividend Yield % 0.6 0.5 105.9%  

Financials

 UNICHEM LAB   AJANTA PHARMA
EQUITY SHARE DATA
    UNICHEM LAB
Mar-16
AJANTA PHARMA
Mar-16
UNICHEM LAB/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs3341,720 19.4%   
Low Rs1741,103 15.8%   
Sales per share (Unadj.) Rs146.9194.6 75.5%  
Earnings per share (Unadj.) Rs11.945.2 26.3%  
Cash flow per share (Unadj.) Rs16.250.3 32.2%  
Dividends per share (Unadj.) Rs2.008.00 25.0%  
Dividend yield (eoy) %0.80.6 138.9%  
Book value per share (Unadj.) Rs105.1132.0 79.6%  
Shares outstanding (eoy) m90.8488.77 102.3%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x1.77.3 23.8%   
Avg P/E ratio x21.431.2 68.4%  
P/CF ratio (eoy) x15.728.1 55.9%  
Price / Book Value ratio x2.410.7 22.6%  
Dividend payout %16.817.7 95.1%   
Avg Mkt Cap Rs m23,073125,299 18.4%   
No. of employees `0005.7NA-   
Total wages/salary Rs m2,5582,570 99.5%   
Avg. sales/employee Rs Th2,352.5NM-  
Avg. wages/employee Rs Th450.9NM-  
Avg. net profit/employee Rs Th190.4NM-  
INCOME DATA
Net Sales Rs m13,34617,275 77.3%  
Other income Rs m192166 115.4%   
Total revenues Rs m13,53817,442 77.6%   
Gross profit Rs m1,6395,807 28.2%  
Depreciation Rs m390451 86.6%   
Interest Rs m2949 58.9%   
Profit before tax Rs m1,4125,474 25.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m-40-   
Extraordinary Inc (Exp) Rs m-350-   
Tax Rs m2931,460 20.0%   
Profit after tax Rs m1,0804,014 26.9%  
Gross profit margin %12.333.6 36.5%  
Effective tax rate %20.726.7 77.7%   
Net profit margin %8.123.2 34.8%  
BALANCE SHEET DATA
Current assets Rs m5,9797,639 78.3%   
Current liabilities Rs m2,4322,715 89.6%   
Net working cap to sales %26.628.5 93.3%  
Current ratio x2.52.8 87.4%  
Inventory Days Days6343 145.9%  
Debtors Days Days6079 76.7%  
Net fixed assets Rs m6,4036,914 92.6%   
Share capital Rs m182177 102.7%   
"Free" reserves Rs m9,29311,442 81.2%   
Net worth Rs m9,54811,721 81.5%   
Long term debt Rs m230149 154.9%   
Total assets Rs m12,84314,814 86.7%  
Interest coverage x50.0112.9 44.3%   
Debt to equity ratio x00 190.2%  
Sales to assets ratio x1.01.2 89.1%   
Return on assets %8.627.4 31.5%  
Return on equity %11.334.2 33.0%  
Return on capital %14.346.5 30.8%  
Exports to sales %29.255.1 53.0%   
Imports to sales %6.36.0 105.6%   
Exports (fob) Rs m3,9009,527 40.9%   
Imports (cif) Rs m8471,038 81.6%   
Fx inflow Rs m4,35610,422 41.8%   
Fx outflow Rs m1,1621,678 69.3%   
Net fx Rs m3,1948,744 36.5%   
CASH FLOW
From Operations Rs m1,1193,264 34.3%  
From Investments Rs m-853-2,093 40.8%  
From Financial Activity Rs m-334-1,186 28.2%  
Net Cashflow Rs m-68-15 461.5%  

Share Holding

Indian Promoters % 50.1 73.8 67.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 1.6 974.2%  
FIIs % 3.0 7.6 39.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 17.0 186.5%  
Shareholders   20,176 20,968 96.2%  
Pledged promoter(s) holding % 0.0 4.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   SANOFI INDIA  TORRENT PHARMA  PLETHICO PHARMA  CIPLA  ABBOTT INDIA  

Compare UNICHEM LAB With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Near Record High; Realty Stocks Bleed(Closing)

After opening the day on a strong note, share markets in India witnessed volatility during the last hour of trading session. However, they managed to end the day on a positive note.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

The ONLY Thing You Need to Know About Bitcoin(The 5 Minute Wrapup)

Jan 6, 2018

You either want it or you want to get as far away from it as possible - but Bitcoin is just the noise masking the REAL opportunity. Read about it here...

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Jan 18, 2018 03:35 PM

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 8-QTR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS